"Bulunduğu bölgede toplumun ruh ve beden sağlığının korunmasını, 3.basamak sağlık kuruluşu olarak üst düzeyde tanı, tedavi, hizmetin çağdaş bilgi ve teknoloji kullanarak sunulmasını sağlayarak hasta, hasta yakını ve çalışan memnuniyeti odaklı uluslararası kalite standartlarında hizmet anlayışı ile bölgenin fark yaratan sağlık merkezi olmak."

During the past decade, Adnan Menderes University Training and Research Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adnan Menderes University Training and Research Hospital" #1 sponsor was "Aydin Adnan Menderes University" with 8 trials, followed by "Pfizer" with 3 trials sponsored, "Camurus AB" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adnan Menderes University Training and Research Hospital" #1 collaborator was "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Adnan Menderes University Training and Research Hospital" are "Acromegaly" (2 trials), "Anesthesia" (2 trials), "Multiple Myeloma" (2 trials), "Cardiac Arrest" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Adnan Menderes University Training and Research Hospital" in a lesser frequency.

Most popular intervention types in "Adnan Menderes University Training and Research Hospital" are "Drug" (10 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CAM2029 (octreotide subcutaneous depot)" (2 trials), "Elranatamab" (2 trials), "%0.9 NaCl 10ml/kg" (1 trials) and "%0.9 NaCl 20ml/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Adnan Menderes University Training and Research Hospital" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Adnan Menderes University Training and Research Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Adnan Menderes University Training and Research Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Adnan Menderes University Training and Research Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".